Company intelligence / Profile preview

Veni Vidi Medical

Rotterdam, South Holland, Netherlands

Ownership: Private
Development stage: Other

Overview

Veni Vidi Medical is a medical technology company focused on developing innovative solutions for the treatment of calcific aortic valve disease. The company's primary focus is on a non-invasive or minimally invasive technology designed to decalcify heart valves, potentially delaying or replacing the need for traditional Transcatheter Aortic Valve Replacement (TAVR) or open-heart surgery. By targeting the underlying calcification that causes aortic stenosis, Veni Vidi Medical aims to restore valve function and improve patient outcomes. The company operates within the cardiovascular space, addressing a significant unmet need in the aging population.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Veni Vidi Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veni Vidi Medical.

Explore the full profile